Facebook Pixel Code
Haematology/Oncology
Haematology/Oncology

Sub-specialties of Paediatric Haematology/Oncology

Further Clinical and/or Research Training in Sub-specialties of Paediatric Haematology/Oncology
Trainees who have completed general paediatric haematology/oncology training and who would like to pursue further sub-specialization can do so in clinical and/or research fields. These include haemoglobinopathy, bone marrow failure and myelodysplasia, thrombosis, leukemia and lymphoma, neuroblastoma, neuro-oncology, childhood cancer survivorship, new agent and innovative therapy, and blood and bone marrow transplantation.

For a complete description of the subspecialties, please click on attached links below: 

BMT Fellowship
Childhood Cancer Survivorship Fellowship
GFCC Research Fellowship
Haemoglobinopathy Fellowship
Leukemia Fellowship
Bone Marrow Failure and Myelodysplasia Fellowship
NAIT Fellowship
Neuroblastoma Fellowship
Neuro-Oncology Fellowship
Thrombosis/Hemostasis Fellowship

BMT Fellowship

The program will run over a twelve month period and shall include 5 months of in-patient clinical service on the BMT unit (8B), 1 month on the Infectious Diseases Immune-compromised consult service, 1 month on the Immunology service with special attention to the diagnosis and management of patients with Severe Combined Immunodeficiency syndrome prior to, during and following SCT, 1 month designated for focusing on their research activity. Three months of the program is in the out-patients setting and includes attendance at clinic (HLA consults, SCT consults & follow-up clinics), ward rounds, applicable teaching rounds and the Leukemia / Lymphoma section weekly rounds and visitation of laboratory services (HLA lab, Blood Bank, Cytogenetics and Molecular lab [Minimal Residual Disease detection and donor chimerism). During the latter time period, the trainee will also participate in evaluating HLA results (family studies, search results) and in supervising patients undergoing mobilization and collection of peripheral blood stem cells. The final month is meant to serve as a buffer for meetings, vacation or an optional posting.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Please complete the online application by clicking on link attached. Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.
Please complete the Clinical Haematology/Oncology Fellowship Application.

Program Contact
Education.haemonc@sickkids.ca

Back to top

Childhood Cancer Survivorship Fellowship

This 1 or 2 year fellowship will provide an opportunity to obtain expert knowledge in the late and long-term effects that occur after treatment of a pediatric malignancy. It will provide exposure to survivors of childhood cancer during their childhood, adolescent and adult years. In addition to understanding the physical late effects of cancer treatment, it will also provide exposure to the neuropsychological, psychosocial and emotional sequelae of the disease and to the challenges of successful transition from pediatric to adult care. Clinical exposure will include:

  • Attendance at weekly After Care clinics for survivors of childhood cancer in the pediatric and adult settings
  • Specialized clinics for survivors of brain tumors  and hematopoietic stem cell transplantation
  • Opportunity for month long rotations with other services that care for specific sequelae of childhood cancer

The fellowship will also provide the opportunity to gain experience in research around survivorship issues. Concurrent completion of a post graduate degree (e.g. in clinical epidemiology or education) will be possible. Fellows will be able to develop projects ranging from basic science to clinical research by taking advantage of the numerous ongoing research initiatives in the Aftercare section, including the Childhood Cancer Survivor Study (CCSS), the Pediatric Oncology Group of Ontario (POGO) childhood cancer registry, genomic studies through the Canadian Pharmacogenomics Network for Drug Safety and two CIHR funded team grants investigating the genomic predictors of cardiac and neurocognitive late effects, the Consortium for Pediatric Interventional Research, and the Children’s Oncology Group’s (COG) Survivorship and Outcomes committee.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Applicants interested should apply online by pressing on link attached. Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.
Please complete the Clinical Haematology/Oncology Fellowship Application.

Program Contact
Education.haemonc@sickkids.ca

Back to top

Garron Family Cancer Centre Fellowship Opportunities

There are 2 pathways by which funding may be obtained for Garron Family Cancer Centre (GFCC) fellowships:

1. Restracomp

For all individuals applying for graduate student or postdoctoral fellowships; this includes paediatric haematology/oncology residents who have completed their clinical training and wish to pursue graduate studies.  There is no clinical requirement with these positions.  There are two categories when applying: “fellows with license” and “fellows without license”; the latter category includes PhD fellows. Restracomp applicants funded by the GFCC must be engaged in cancer-related research.
 
Deadlines for application are published on the Research Institute website. Restracomp competitions are only held once a year (usually in the spring), but applicants can apply up to one year prior to planned arrival. Applicants are vetted through a Research Institute-coordinated peer review process.

Please refer to the Research Training Site for more information

2. GFCC Research Fellowship

The Garron Family Cancer Centre (GFCC) offers unique fellowship opportunities for clinical fellows, nurses, pharmacists, allied health trainees and basic science investigators engaged in cancer research. The GFCC, as part of The Hospital for Sick Children, is one of Canada's top ranked Paediatric Oncology Centres in Canada.  These fellowship opportunities aim to provide training through direct participation in basic science or clinical investigation under the supervision of world leaders in oncology research and clinical care. The goal is to promote career development in the clinician/investigator and clinician/scientist tracks.

For more information on the GFCC Fellowship opportunities, visit the website here or e-mail garronfamily.cancercentre@sickkids.ca.

 

 

Back to top

Haemoglobinopathies Fellowship

Description/Summary
We are pleased to announce the availability of a combined clinical and research fellowship in Pediatric Haemoglobinopathies. The program offers a stimulating environment where fellows learn the principles of clinical and research and collaborate with investigators across Canada. About 50-60 per cent of the time is protected for basic/translational or clinical research. Clinical duties include outpatient and inpatient care and night calls from home.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Applicants interested, should apply by clicking on the link below. Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.

Please complete the Clinical Haematology/Oncology Fellowship Application.

Program Contact
Education.haemonc@sickkids.ca

Back to top

Leukemia Research

Description/Summary
From September 2009, the Christopher Brundage Endowment Fund will be used to support a post-doctoral leukemia research fellowship. The goal is to train leading investigators in leukemia research. The term of the fellowship is 2 years. The research area encompasses experimental, clinical or translational research in childhood leukemia. The research will be conducted at SickKids. Fellows will be selected by a committee of the Leukemia Research Group within the Comprehensive Cancer Centre at SickKids.

Eligibility
Eligible candidates are postgraduate trainees who are either post-doctoral research fellows or medical trainees committed to a career track focused on leukemia research.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Please note that this could be a clinical, research or a combined clinical/Research fellowship. Applicants interested in the research component only, please apply by submitting the GFCC Application package attached below to Gfcc.fellowship@sickkids.ca

Applicants interested in the clinical component only, please apply by clicking on the link below. Applicants interested in a clinical research fellowship, please apply by clicking on the link AND submitting the GFCC Package attached below.

Please complete the Clinical Haematology/Oncology Fellowship Application.

Complete GFCC package should be sent to:
Gfcc.fellowship@sickkids.ca

Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.

Program Contact
Gfcc.fellowship@sickkids.ca

Back to top

Bone Marrow Failure and Myelodysplasia Fellowship

Description/Summary
We are pleased to announce the availability of a combined clinical and research fellowship in paediatric bone marrow failure and Myelodysplasia in one of the largest paediatric marrow failure and Myelodysplasia programs in the world. The program offers a stimulating environment where fellows learn the principles of clinical and research and collaborate with investigators across Canada. About 50-70 per cent of the time is protected for basic/translational or clinical research. Clinical duties include outpatient and inpatient care and night calls from home.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Applicants interested should apply by clicking on link below. Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.

Please complete the Clinical Haematology/Oncology Fellowship Application.

Program Contact
Education.haemonc@sickkids.ca

Back to top

New Agent and Innovative Therapy Program (NAIT)

Description/Summary
The program will run over a twelve to twenty four month period with the goal of providing experiences in (1) outpatient experimental therapy /phase 1  clinic program, (2) translational research in  several labs including Dr Baruchel’s  labs  with interest in  pharmacology biomarker/ preclinical model for drug  development  related projects, and (3) experimental therapies/ protocol development. The program and relative duration for each component may be personalized to the interests of the applicant.  Our phase 1 Program sees an  average  of 12 to 15   new patients per year and additional local, national and international consultations, including patients with relapsed or refractory leukemias/solid tumors/brain tumors. The  NAIT  program  is an active  member of the  COG  Phase  1  consortium , TACL , NANT,  NCIC C17  consortium and participates  to  industry  sponsored and  investigator initiated trials . An MIBG therapeutic facility is opening   open in early 2014 .  Applicants will also be expected to provide some call coverage(10-15% effort), which is most commonly weekend daytime coverage on the in-patient ward. Applicants are also encouraged to apply to the GFCC clinician-scientist fellowship.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Please note that this could be a clinical, research or a combined clinical/Research fellowship. Applicants interested in the research component only, please apply by submitting the GFCC Application package attached below to Gfcc.fellowship@sickkids.ca

Applicants interested in the clinical component only, please apply by clicking on the link below. And for applicants interested in clinical research fellowship, please apply by clicking on the link AND submitting the GFCC Package attached below.

Please complete the Clinical Haematology/Oncology Fellowship Application.
 

Complete GFCC package should be sent to:
Gfcc.fellowship@sickkids.ca

Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.

Program Contact
Gfcc.fellowship@sickkids.ca

Back to top

Neuroblastoma

Description/Summary
The program will run over a twelve to twenty four month period with the goal of providing experiences in two or more of the following: (1) outpatient neuroblastoma clinic program, (2) translational research (in one of a number of labs with neuroblastoma related projects), and (3) experimental therapies/ protocol development and MIBG program. The fellowship and relative duration for each component may be personalized to the interests of the applicant.  Our Neuroblastoma Program has approximately 25 new patients per year and additional local, national and international consultations, including patients with refractory neuroblastoma and genetic predisposition to neuroblastoma.. Active neuroblastoma research projects include, but are not limited to (1) tumor initiating cell/ cancer stem cells, (2) murine metastatic models, (3) drug screening, (4) neuroblastoma cell signaling and apoptosis, (5) genetic predisposition to neuroblastoma.  Applicants will also be expected to provide some call coverage (10-15% effort), which is most commonly weekend daytime coverage on the in-patient ward. Applicants are also encouraged to apply to the GFCC Research Fellowship.

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

Application Process
Please note that this could be a clinical, research or a combined clinical/Research fellowship. Applicants interested in the research component only, please apply by submitting the GFCC Application package attached below to Gfcc.fellowship@sickkids.ca

Applicants interested in the clinical component only, please apply by clicking on the link below. And for applicants interested in clinical research fellowship, please apply by clicking on the link AND submitting the GFCC Package attached below.

Please complete the Clinical Haematology/Oncology Fellowship Application.
 

Complete GFCC package should be sent to:
Gfcc.fellowship@sickkids.ca

Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.

Program Contact
Gfcc.fellowship@sickkids.ca

Back to top

Meagan's Walk Fellowship in Paediatric Neuro-Oncology at the Hospital for Sick Children

This 1(-3) year academic clinical and/or research fellowship will provide the successful candidate with an opportunity to train in one of the largest, most world renowned paediatric brain tumour program  (www.sickkids.ca/haematologyoncology/index.html) and affiliated paediatric brain tumour research centres in the world (www.sickkids.ca/Research/BTRC/).  The combined clinical and research programs have a global reputation for state-of-the-art multi-disciplinary care of paediatric brain tumour patients, and excellence in clinical and research training. Fellows will have the option to pursue a strict 12 month clinical training program with opportunities to develop the clinical academic skills necessary to practice as an expert consultant in paediatric neuro-oncology at the highest level, or to pursue additional academic training. The Paediatric Brain Tumour Program at SickKids sees between 80-100 primary diagnosis/year, and also consults directly or via e-communications for 50-60 patients worldwide. There are dedicated international twinning programs for clinical care and clinical research with centres in Jordan, Morocco, Pakistan, the AHOPCA (Central America) group, and others. Trainees are mentored to develop strong clinical academic skills through involvement in clinical trials, preparation of clinical manuscripts, involvement in focused clinical projects and attendance at international meetings.  Fellows who have an interest in further clinical academic or translational/basic research training beyond the core 12 month clinical neuro-oncology training will have opportunities to be considered for research funding through the prestigious Garron Family Centre Research Fellowship in Pediatric Hematology/Oncology, and work with faculty investigators with research expertise in clinical or translational/basic science.

Eligibility Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.

Application Deadline Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)

 Application Process
Please apply by clicking on the link attached below. Interviews will be conducted in May. Notification of decisions will be sent out by July 1st.
Please complete the Clinical Haematology/Oncology Fellowship Application.

Program Contact
Education.haemonc@sickkids.ca

Back to top

Thrombosis/Hemostasis Fellowship

The Pediatric  Thrombosis and Hemostasis  Fellowship in the Division of Hematology/Oncology  at the Hospital for Sick Children (SickKids)  , Toronto , Canada is a combined clinical and research fellowship which may be taken over one, two or three years, at an internationally renowned centre in the area of childhood bleeding and clotting disorders. Launched by the visionary work of Dr. Victor Blanchette on the bleeding side, and Dr. Maureen Andrew on the clotting side, the program at The Hospital for Sick Children has trained paediatric haemostasis and thrombosis experts for over two decades, changing the landscape of this area. Graduates of the program have gone on to successful academic and clinical careers in centres around the world.

For all candidates accepted into the program at SickKids, the first year is primarily clinical, including 6 months in Thrombosis and Haemostasis  in-patient and out-patient clinical services (including the pediatric comprehensive care hemophilia program) , 1 month in the in-patient and out-patient pediatric  Stroke service, 2 months of laboratory training, and 3 months of elective rotations.
The second and third year (optional) may either be a) primarily research (laboratory-based or clinical, centred on the study of Pediatric Thrombosis  and Haemostasis ); or b) a combination of clinical work and research. In the first case (a), the fellow will work under the supervision of a member of the  Thrombosis and Hemostasis  team. In the second case (b), the fellow may design a custom schedule to fulfill their personal needs from a variety of clinical rotations throughout the hospital network. The schedule will be  determined prior to the start of the year in consultation with the Medical Director of the Pediatric Thrombosis and Hemostasis Program , Dr  Victor Blanchette.

For both streams outlined above, fellows are expected to contribute to a minimal of clinical coverage. Such activities comprise attendance to one of the continuity clinics (one day per week) over 1-2 years, as well as participation in the on-call thrombosis schedule throughout their fellowship.For all research projects, the fellow will be expected to present a research proposal, an interim report and a final report to the Division, with the goal of publication within 6 months from termination of the fellowship.
 

Eligibility
Applicants should be certified or board-eligible in Paediatric Hematology/Oncology or General Haematology. Applicants may be Canadian or international citizens.
 

Application Deadline
Deadline for application is April 30th for a start date of July 1st of the following year (ie. April 30th, 2017 for a start date of July 1, 2018.)


Please complete the Clinical - Subspecialty (1 or 2 year program) Fellowship Application

For more information, please contact:

Marta Vila
Education Program Administrator
Division of Haematology/Oncology
The Hospital for Sick Children
Email: Education.haemonc@sickkids.ca